1.
Prevalence and differentiation of hereditary breast and ovarian cancers in Japan
by Nakamura, Seigo
Breast cancer (Tokyo, Japan), 2013-11-19, Vol.22 (5), p.462-468
2.
Triple-negative breast carcinoma: current and emerging concepts
by Schmadeka, Robert
American journal of clinical pathology, 2014-04, Vol.141 (4), p.462-477
3.
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
by Davies, Helen
Nature Medicine, 2017, Vol.23 (4), p.517-+
4.
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
by Lin, Chang-Ching Chang-Ching
Cancer letters, 2018-09-15, Vol.438, p.165-173
5.
Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression
by El-Shinawi, Mohamed
Annals of surgical oncology, 2015-10-27, Vol.23 (2), p.494-502
6.
Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype
by Lee, Kyuongyul
Human pathology, 2016, Vol.61, p.111-120
7.
Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence
by Ortiz-Martínez, Fernando, PhD
Human pathology, 2014, Vol.45 (3), p.504-512
8.
Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer
by Kim, Sinae
Cancer letters, 2014, Vol.357 (2), p.488-497
9.
Dicer Expression in Estrogen Receptor Positive versus Triple-Negative Breast Cancer: An Antibody Comparison
by Spoelstra, Nicole S., BS
Human pathology, 2016, Vol.56, p.40-51
10.
Functional relationship of SNP (Ala490Thr) of an epigenetic gene EZH2 results in the progression and poor survival of ER+/tamoxifen treated breast cancer patients
by Gautam, Nisha
Journal of genetics, 2021-11-16, Vol.100 (2)
11.
Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype
by Titloye, N.A
Pathobiology (Basel), 2016-03, Vol.83 (1), p.24-32
12.
PGC-1β regulates HER2-overexpressing breast cancer cells proliferation by metabolic and redox pathways
by Victorino, Vanessa Jacob
Tumor biology, 2015-11-24, Vol.37 (5), p.6035-6044
13.
Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
by Thompson, Deborah
American journal of human genetics, 2001, Vol.68 (2), p.410-419
14.
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer
by Zhu, Liang
Breast cancer (Tokyo, Japan), 2021-08-17, Vol.29 (1), p.103-113
15.
Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study
by Han, Mi-Ryung
Breast cancer (Tokyo, Japan), 2014-02-09, Vol.22 (5), p.544-551
16.
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers
by van der Post, Rachel S
Journal of Medical Genetics, 2015-06, Vol.52 (6), p.361-374
17.
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gas...
by Doi, Toshihiko
The lancet oncology, 2017-11, Vol.18 (11), p.1512-1522
18.
No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women
by Dorjgochoo, Tsogzolmaa
Cancer epidemiology, 2013, Vol.37 (5), p.619-624
19.
Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer
by Chen, Fei
Tumor biology, 2015-10-07, Vol.37 (3), p.3365-3370
20.
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
by Mavaddat, Nasim Nasim
American journal of human genetics, 2018-12-13, Vol.104 (1), p.21-34
